Spravato Treatment in Independence, MO

At Success Health System, we are committed to offering innovative solutions for individuals struggling with treatment-resistant depression. One of the advanced therapies available at our practice is Spravato (esketamine) nasal spray.

Spravato (esketamine) is a nasal spray used to treat treatment-resistant depression in adults. It is a fast-acting medication that works differently from traditional antidepressants. Spravato targets specific brain receptors, which help to improve mood and alleviate symptoms of depression by restoring balance in brain chemistry.

Unlike oral antidepressants that can take weeks to show effects, Spravato provides quicker relief. It is typically used for patients who have not found relief from other medications and is administered under medical supervision in a healthcare setting to ensure safety. It can be an important tool for people struggling with severe depression when other treatments have not worked.

At Success Health System, we are committed to providing effective treatments like Spravato to help individuals struggling with treatment-resistant depression. Led by Dr. Moses Tabe Ambilichu, M.D., our team offers a safe, supportive environment where patients receive the care they need to manage their mental health. If you’re seeking an alternative treatment for depression, contact us today to learn more about how Spravato can help you on your journey to recovery.

Spravato (esketamine) is administered as a nasal spray under the supervision of a healthcare provider. The treatment takes place in a medical setting, such as a clinic, to ensure patient safety. During the session, the patient inhales the nasal spray, and the medication is absorbed through the nasal mucosa.

After administration, patients are monitored for at least two hours to observe for any side effects or reactions. This monitoring period is important because Spravato can cause dizziness, nausea, or sedation, and it’s essential to ensure the patient’s well-being during this time. The treatment is typically given in a series of sessions, with frequency decreasing over time as symptoms improve.

Spravato at Success Health System is typically prescribed alongside an oral antidepressant, and your treatment plan—including the frequency and duration of sessions—will be tailored by your provider to your specific needs and response to therapy. Your well-being and safety are our top priorities as we help you take the next step toward improved mental health.

At Success Health System, our experienced team provides Spravato (esketamine) treatment for adults struggling with treatment-resistant depression. You may be a good candidate for Spravato if you have not found sufficient relief from at least two different antidepressant medications taken at the appropriate doses and durations. We may also consider Spravato for adults diagnosed with major depressive disorder who are experiencing acute suicidal thoughts or behaviors, always as part of a comprehensive, closely monitored treatment plan that includes oral antidepressants and ongoing support.

Before starting Spravato, every patient undergoes a thorough medical and psychiatric evaluation to ensure safety and appropriateness. Spravato may not be suitable for individuals with certain medical conditions, such as aneurysmal vascular disease, a history of intracerebral hemorrhage, or hypersensitivity to esketamine or ketamine. Additionally, patients with uncontrolled high blood pressure or a history of substance use disorder may not be eligible, as the medication can elevate blood pressure and carries a risk of misuse.

At Success Health System, Spravato is always administered under the supervision of our healthcare professionals in our certified treatment facility. We prioritize your safety by providing careful monitoring during and after each treatment session, and we are committed to supporting you every step of the way on your journey to better mental health.

The success rate of Spravato (esketamine) varies, but it has shown promising results, especially for those with treatment-resistant depression. In clinical trials, about 65% of patients experienced a positive response to Spravato, meaning they saw at least a 50% reduction in their depression symptoms. Around 32% of participants achieved remission, meaning their symptoms were significantly reduced or minimal. These results suggest that Spravato can be highly effective for individuals who haven’t found relief from other treatments.

In real-world settings, Spravato has continued to show effectiveness. A study of over 660 patients found that 85% of individuals, including those with treatment-resistant depression, experienced a clinical response. While individual results may vary, Spravato has proven to be a valuable option for many patients struggling with severe depression that hasn’t responded to other medications.

At Success Health System, we understand that everyone’s journey with depression is unique. While Spravato offers new hope, it’s important to know that individual responses may vary. Our providers will work closely with you to monitor your progress, adjust your treatment plan as needed, and offer ongoing support. For those who respond well to Spravato, continuing with maintenance dosing can help sustain improvement over time. Our team will guide you through each phase of treatment and answer any questions you may have about your care.

At Success Health System LLC in Independence, MO, Dr. Moses Tabe Ambilichu, M.D., a board-certified psychiatrist, ensures that each patient receives safe and personalized care when undergoing Spravato (esketamine) treatment. The process begins with a comprehensive evaluation of the patient’s medical history, current symptoms, and previous treatment outcomes. Dr. Ambilichu takes the time to assess whether Spravato is the right fit based on the individual’s specific needs, especially for those with treatment-resistant depression or other mental health conditions. This careful consideration ensures that patients are fully informed and prepared for the treatment process.

Once treatment is initiated, Dr. Ambilichu personally administers Spravato in a controlled, clinical environment, where patients are closely monitored for safety and comfort. He adjusts the dosing schedule and therapy plan based on each patient’s response to the treatment, ensuring it is effective and tailored to their unique mental health needs. By maintaining a collaborative and hands-on approach, Dr. Ambilichu provides ongoing support, allowing patients to feel confident in their treatment while improving their mental well-being.

Contact us for more information or schedule an appointment online! We are conveniently located at 4429 S River Blvd, Ste D, Independence MO, 64055. We serve patients from Independence MO, Raytown MO, Sugar Creek MO, Blue Springs MO, Kansas City MO, Lee’s Summit MO and surrounding areas.